These materials are provided to support scientific investigation and are not intended for human consumption or medical use
May Support the Immune System May Relieve Certain Respiratory Symptoms Some evidence suggests that delivering intravenous (IV) glutathione may relieve shortness of breath associated with COVID-19 and COVID-19 pneumonia (a lung infection caused by the SARS-COV-2 virus)
Custom Protocol Personalized treatment plan with precise dosing, application method (subcutaneous, topical, or combination), frequency schedule, and complementary therapies
Consider topical only for localized skin conditions, and recognize its bioavailability limitations
Ritter W, Paavilainen P, Lavikainen J, Reinikainen K, Alho K, Sams M et al (1992)